A review of the major vascular risk factors related to Alzheimer's disease

Journal of Alzheimer's Disease

Volumn 32, Issue 3, 2012, Pages 521-530

  Polidori, M Cristina ^a   Pientka, Ludger ^a   Mecocci, Patrizia ^b  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Alzheimer's disease; cardiac diseases; cognitive impairment; dementia; diabetes; hypercholesterolemia; hypertension; metabolic syndrome; obesity; vascular risk factors

Indexed keywords

ALZHEIMER DISEASE; ANAMNESIS; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; COGNITION; COGNITIVE DEFECT; DIABETES MELLITUS; EXERCISE; HEART DISEASE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; LIFESTYLE; METABOLIC SYNDROME X; OBESITY; PHYSICIAN; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; REVIEW; SOCIAL BEHAVIOR;

EID: 84871398906     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2012-120871     Document Type: Review

References (96)

1. George DR, Whitehouse PJ, Ballenger J (2011) The evolving classification of dementia: Placing the DSM-V in a meaningful historical and cultural context and pondering the future of 'Alzheimer's'. Cult Med Psychiatry 35, 417-435.
2. Kalaria RN, Maestre GE, Arizaga R, Friedland RP, Galasko D, Hall K, Luchsinger JA, Ogunniyi A, Perry EK (2008) alzheimer's disease and vascular dementia in developing countries: Prevalence, management, and risk factors. Lancet Neurol 7, 812-826.
3. Freyham FA, Woodford WB, Kety SS (1951) Cerebral blood flow and metabolism in psychosis of senility. J Nerv Ment Dis 113, 455-456.
4. Lassen NA, Munck O, Tottery ER (1957) Mental function and cerebral oxygen consumption in organic dementia. Arch Neurol Psychiatry 77, 126-133.
5. Hachinski VC, Iliff LD, Zihlkas E, Du Boulay GH, McAllister VL, Marshall J, Ross Russell RW, Symon L (1975) Cerebral blood flow in dementia. Arch Neurol 32, 632-637.
6. Editorial (1977) Cardiogenic dementia. Lancet ii, 27-28.
7. Emerson TR, Milne JR, Gardner AJ (1981) Cardiogenic dementia - A myth? Lancet 2, 743-744. (Pubitemid 11061105)
8. Polidori MC, Marvardi M, Cherubini A, Senin U, Mecocci P (2001) Heart disease and vascular risk factors in the cognitively impaired elderly: Implications for alzheimer's dementia. Aging Clin Exp Res 13, 1-9.
9. Polidori MC, Mariani E, Mecocci P, Nelles G (2006) Congestive heart failure in alzheimer's disease. Neurol Res 28, 588-594. (Pubitemid 44433317)
10. Breteler MMB (2000) Vascular involvement in cognitive decline in dementia; epidemiologic evidence from The rotterdam study and the Rotterdam Scan Study. Ann NY Acad Sci 903, 457-465. (Pubitemid 30251589)
11. Hofman A, Breteler MMB, van Duijn CM, Janssen HLA, Krestin GP, Kuipers EJ, Stricker BHC, Tiemeier H, UitterlindenAG, Vingerling JR,WittemanJCM(2009) The rotterdam study: 2010 objectives and design update. Eur J Epidemiol 24, 553-572.
12. Zhu X, Raina AK, Perry G, Smith MA (2004) alzheimer's disease: The two-hit hypothesis. Lancet 3, 219-226.
13. De la Torre J (2000) Critically attained threshold of cerebral hypoperfusion: The CATCH hypothesis of alzheimer's pathogenesis. Neurobiol Aging 21, 331-342. (Pubitemid 30387092)
14. Agüero-Torres H, Kivipelto M, von Strauss E (2006) Rethinking the dementia diagnoses in a population-Based study: What is alzheimer's disease and what is vascular dementiaästudy from the Kungsholmen Project. Dement Geriatr Cogn Disord 22, 244-249. (Pubitemid 44310521)
15. Clausen J (1984) Demential syndromes and the lipid metabolism. Acta Neurol Scand 70, 345-355. (Pubitemid 14023099)
16. Pappolla MA, Smith MA, Bryant-Thomas T, Bazan N, Petanceska S, Perry G, Thal LJ, Sano M, Refolo LM (2002) Cholesterol, oxidative stress, and alzheimer's disease: Expanding the horizons of pathogenesis. Free Radic Biol Med 33, 173-181. (Pubitemid 34775189)
17. Polidori MC, Pientka L, Nelles G, Griffiths HR (2010) Modulation of cholesterol in midlife affords cognitive advantage during ageing - A role for altered redox balance. Int J Clin Exp Med 3, 103-109.
18. Polidori MC, Pientka L (2012) Bridging the pathophysiology of alzheimer's disease with vascular pathology: The feedback, the feed-forward, and oxidative stress. J Alzheimers Dis 28, 1-9.
19. Notkola IL, Sulkava R, Pekkanen J, Erkinjuntti T, Ehnholm C, Kivinen P, Tuomilehto J, Nissinen A (1998) Serum total cholesterol, apolipoproteinEepsilon 4 allele, and alzheimer's disease. Neuroepidemiology 17, 14-20. (Pubitemid 28153361)
20. Romas SN, Tang MX, Berglund L, Mayeux R (1999) APOE genotype, plasma lipids, lipoproteins, and AD in community elderly. Neurology 53, 517-521. (Pubitemid 29382044)
21. Wolozin B, Kellman W, Ruosseau P, Celesia GG, Siegel G (2000) Decreased prevalence of alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors. Arch Neurol 57, 1439-1443.
22. Kivipelto M, Helkala EL, Laakso MP, Hänninen T, Hallikainen M, Alhainen K, Soininen H, Tuomilehto J, Nissien A (2001) Midlife vascular risk factors and alzheimer's disease in later life: Longitudinal, population based study. BMJ 322, 1447-1451. (Pubitemid 32575406)
23. Kivipelto M, Helkala EL, Laakso MP, Hänninen T, Hallikainen M, Alhainen K, Iivonen S, Mannermaa A, Tuomilehto J, Nissinen A, Soininen H (2002) Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-Life alzheimer disease. Ann Intern Med 137, 149-155. (Pubitemid 34827510)
24. Kivipelto M, Helkala EL, Hänninen T, Laakso MP, Hallikainen K, Soininen H, Tuomilehto J, Nissinen A (2001) Midlife vascular rsik factors and late-Life mild cognitive impairment: A population-Based study. Neurology 56, 16831689. (Pubitemid 32574567)
25. Kivipelto M, SolomonA(2006) Cholesterol as a risk factor for alzheimer's disease - Epidemiological evidence. Acta Neurol Scand 185, 50-57. (Pubitemid 44015225)
26. Solfrizzi V, Panza F, Colacicco AM, rsquo, D'Introno A, Capurso C, Torres F, Grigoletto F, Maggi S, Del Parigi A, Reiman EM, Caselli RJ, Scafato E, Farchi G, Capurso A, Italian Longitudinal Study on Aging Working Group (2004) Vascular risk factors, incidence of MCI, and rates of progression to dementia. Neurology 63, 1882-1891. (Pubitemid 39532385)
27. Pappolla MA, Bryant-Thomas TK, Herbert D, Pacheco J, Fabra Garcia M, Manjon M, Girones X, Henry TL, Matsubara E, Zambon D, Wolozin B, Sano M, Cruz-Sanchez FF, Thal LJ, Petanceska SS, Refolo LM (2003) Mild hypercholesterolemia is an early risk factor for the development of alzheimer amyloid pathology. Neurology 61, 199-205. (Pubitemid 36875301)
28. Wolf H, Hensel A, Arendt T, Kivipelto M, Winblad B, Gertz HJ (2004) Serum lipids and hippocampal volume: The link to alzheimer's disease? Ann Neurol 56, 745-748. (Pubitemid 39540761)
29. Matsuzaki T, Sasaki K, Hata J, Hirakawa Y, Fujimi K, Ninomiya T, Suzuki SO, Kanba S, KiyoharaY, Iwaki T (2011) Association of alzheimer disease pathology with abnormal lipid metabolism: The hisayama study. Neurology 77, 106810675.
30. Mielke MM, Zandi PP, Sjögren M, Gustafson D, Ostling S, Steen B, Skoog I (2005) High total cholesterol levels in late life associated with a reduced risk of dementia. Neurology 64, 1689-1695. (Pubitemid 40695799)
31. van Vliet P, Westendorp RG, van Heemst D, de Craen AJ, Oleksik AM (2010) Cognitive decline precedes late-Life longitudinal changes in vascular risk factors. J Neurol Neurosurg Psychiatry 81, 1028-1032.
32. Solomon A, Kivipelto M, Wolozin B, ZZhou JJ, Whitmer RA (2009) Midlife serum cholesterol and increased risk of alzheimer's and vascular dementia three decades later. Dem Geriatr Cogn Disord 28, 75-80.
33. Tan ZS, Seshadri S, Beiser A, Wilson PWF, Kiel DP, Tocco M, D'Agostino RB, Wolf PA (2003) Plasma total cholesterol level as a risk factor for alzheimer's disease. Arch Int Med 163, 1053-1057. (Pubitemid 36548931)
34. Kalmijn S, Foley D,White L, Burchfiel CM, Curb JD, Petrovitch H, Ross GW, Havlik RJ, Launer LJ (2000) Metabolic cardiovascular syndrome and risk of dementia in JapaneseAmerican elderly men The Honolulu-Asia aging study. Arterioscler Thromb Vasc Biol 20, 2255-2260.
35. Reynolds CA, Gatz M, Prince JA, Berg S, PedersenNL(2010) Serum lipid levels and cognitive change in late life. J Am Geriatr Soc 58, 501-509.
36. Shobab LA, Hsiung GY, Feldman HH (2005) Cholesterol in alzheimer's disease. Lancet Neurol 4, 841-852.
37. Anstey KJ, Lipnicki DM, Low LF (2008) Cholesterol as a risk factor for dementia and cognitive decline: A systematic review of prospective studies with meta-Analysis. Am J Geriatr Psychiatry 16, 343-354.
38. Shepardson NE, Shankar GM, Selkoe DJ (2011) Cholesterol level and statin use in alzheimer disease: I. Review of epidemiological and preclinical studies. Arch Neurol 68, 1239-1244.
39. Shepardson NE, Shankar GM, Selkoe DJ (2011) Cholesterol level and statin use in alzheimer disease: II. Review of human trials and recommendations. Arch Neurol 68, 13851392.
40. Kokmen E, Beard CM, Chandra V, Offord KP, Schoenberg BS, Ballard DJ (1991) Clinical risk factors for alzheimer's disease: A population-Based case-control study. Neurology 41, 1393-1397.
41. EliasMF,Wolf PA, D'Agostino RB, Cobb J, White LR (1993) Untreated blood pressure level is inversely related to cognitive functioning: The Framingham Study. Am J Epidemiol 138, 353-364. (Pubitemid 23289288)
42. Kilander L, Nyman H, BobergM, Hansson L, LithellH(1998) Hypertension is related to cognitive impairment: A 20-year follow-up of 999 men. Hypertension 31, 780-786. (Pubitemid 28108576)
43. Yamada M, Kasagi F, Sasaki H, Masunari N, Mimori Y, Suzuki G (2003) Association between dementia and midlife risk factors: The Radiation Effects Research Foundation Adult Health Study. J Am Geriatr Soc 51, 410-414. (Pubitemid 36348905)
44. Wu C, Zhou D, Wen C, Zhang L, Como P, Qiao Y (2003) Relationship between blood pressure and alzheimer's disease in Linxian County, China. Life Sci 72, 1125-1130.
45. Whitmer RA, Sidney S, Selby J, Johnston SC, Yaffe K (2005) Midlife cardiovascular risk factors and risk of dementia in late life. Neurology 64, 277-278.
46. FreitagMH,Peila R, Masaki K, Petrovitch H, RossGW,White LR, Launer LJ (2006) Midlife pulse pressure and incidence of dementia: The Honolulu-Asia Aging Study. Stroke 37, 3337.
47. Kloppenborg RP, van den Berg E, Kappelle LJ, Biessels GJ (2008) Diabetes and other vascular risk factors for dementia: Which factor matters most? A systematic review. Eur J Pharmacol 585, 97-108.
48. Kennelly SP, Lawlor BA, Kenny RA (2009) Blood pressure and dementia - A comprehensive review Ther Adv Neurol Disord 2, 241-260.
49. Purnell C, Gao S, Callahan CM, Hendrie HC (2009) Cardiovascular risk factors and incident alzheimer disease: A systematic review of the literature. alzheimer Dis Assoc Disord 23, 1-10.
50. Skoog I, Lernfelt B, Landhal S, Palmertz B, Andreasson LA, Nilsson L, Persson G, Od'en A, Svanborg A (1999) 15-year longitudinal study of blood pressure and dementia. Lancet 347, 1141-1145.
51. Qiu C, Winblad B, Fratiglioni L (2005) The age-Dependent relation of blood pressure to cognitive function and dementia. Lancet Neurol 4, 487-499. (Pubitemid 40982459)
52. Tzourio C, Dufouil C, Ducimetìere P, Alp'erovitch A (1999) Cognitive decline in individuals with high blood pressure: A longitudinal study in the elderly. EVA Study Group. Epidemiology of Vascular Aging. Neurology 53, 19481952.
53. Joas E, Bäckman K, Gustafson D, Ostling S, Waern M, Guo X, Skoog I (2012) Blood pressure trajectories from midlife to late life in relation to dementia in women followed for 37 years. Hypertension 59, 796-801.
54. Shah NS, Vidal JS, Masaki K, Petrovitch H, Ross GW, Tilley C, Demattos RB, Tracy RP, White LR, Launer LJ (2012) Midlife blood pressure, plasma-Amyloid, and the risk for alzheimer disease: The Honolulu Asia Aging Study. Hypertension 59, 780-786.
55. Patterson C, FeightnerJW, Garcia A, Hsiung JYR, MacKnight C, Sadovnick AD (2008) Diagnosis and treatment of dementia: 1. Risk assessment and primary prevention of alzheimer disease. CMAJ 178, 548-556. (Pubitemid 351413998)
56. Barnes DE, Yaffe K (2011) The projected effect of risk factor reduction on alzheimer's disease prevalence. Lancet 10, 819828.
57. Panza F, Frisardi V, Capurso C, Imbimbo BP, Vendemiale G, Santamato A, D'Onofrio G, Seripa D, Sancarlo D, Pilotto A, Solfrizzi V (2010) Metabolic syndrome and cognitive impairment: Current epidemiology and possible underlying mechanisms. J Alzheimers Dis 21, 691-724.
58. Leibson CL, Rocca WA, Hanson VA, Cha R, Kokmen E, O'Brien PC, Palumbo PJ (1997) Risk of dementia among persons with diabetes mellitus: A population-Based cohort study. Am J Epidemiol 145, 301-308. (Pubitemid 27082028)
59. Perlmutter LC, Hakami MK, Hodgson-Harrington C (1984) Decreased cognitive function in aging non-insulin-Dependent diabetic patients. Am J Med 77, 1043-1048. (Pubitemid 15221767)
60. Mooradian AD, Perryman K, Fitten J (1988) Cortical function in elderly non-insulin dependent diabetic patients: Behavioural and electrophysiologic studies. Arch Intern Med 148, 2369-2372.
61. U'Ren RC, Riddle MC, Lezak MD (1990) The mental efficiency of the elderly person with type II diabetes mellitus. J Am Geriatr Soc 38, 505-510. (Pubitemid 20177810)
62. Reaven GM, Thompson LW, Nahum D (1990) Relationship between hyperglycemia and cognitive function in older NIDDM patients. Diabetes Care 13, 16-21. (Pubitemid 20024725)
63. Croxson SCM, Jagger C (1995) Diabetes and cognitive impairment: A community-Based study of elderly subjects. Age Ageing 24, 421-424.
64. Katzman R, Aronson M, Fuld P (1989) Development of dementing illnesses in an 80-year-old volunteer cohort. Ann Neurol 25, 317-324. (Pubitemid 19104162)
65. Ott A, Stolk RP, Hofman A, van Harskamp F, Grobbee DE, Breteler MM (1996) Association of diabetes mellitus and dementia: The rotterdam study. Diabetologia 39, 1392-1397. (Pubitemid 26356072)
66. Akomolafe A, Beiser A, Meigs JB, Au R, Green RC, Farrer LA,Wolf PA, Seshadri S (2006) Diabetes mellitus and risk of developing alzheimer disease: Results from the Framingham Study. Neurology 67, 1960-1965.
67. Arvanitakis Z, Schneider JA, Wilson RS, Li Y, Arnold SE, Wang Z, Bennett DA (2006) Diabetes is related to cerebral infarction but not to AD pathology in older persons. Arch Neurol 63, 1551-1555.
68. Hayden KM, Zandi PP, Lyketsos CG, Khachaturian AS, Bastian LA, Charoonruk G, Tschanz JT, Norton MC, Pieper CF, Munger RG, Breitner JC, Welsh-Bohmer KA, Cache County Investigators (2001) Vascular risk factors for incident alzheimer disease and vascular dementia: The Cache County study. Am J Epidemiol 154, 635-641.
69. Luchsinger JA, Tang MX, Stern Y, Shea S, Mayeux R (2006) Diabetes mellitus and risk of alzheimer's disease and dementia with stroke in a multiethnic cohort. alzheimer Dis Assoc Disord 20, 93-100.
70. MacKnight C, Rockwood K, Awalt E, McDowell I (2002) Diabetes mellitus and the risk of dementia, alzheimer's disease and vascular cognitive impairment in the Canadian Study of Health and Aging. Dement Geriatr Cogn Disord 14, 7783.
71. Peila R, Rodriguez BL, Launer LJ, Honolulu-Asia Aging Study (2002) Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study. Diabetes 51, 1256-1262. (Pubitemid 34438377)
72. Tyas SL, Manfreda J, Strain LA, Montgomery PR (2001) Risk factors for alzheimer's disease: A population-Based, longitudinal study in Manitoba, Canada. Int J Epidemiol 30, 590-597. (Pubitemid 32600256)
73. Xu WL, Qiu CX, Wahlin A, Winblad B, Fratiglioni L (2004) Diabetes mellitus and risk of dementia in the Kungsholmen project: A 6-year follow-up study. Neurology 63, 11811186. (Pubitemid 39350014)
74. Yoshitake T, Kiyohara Y, Kato I, Ohmura T, Iwamoto H, Nakayama K, Ohmori S, Nomiyama K, Kawano H, Ueda K (1995) Incidence and risk factors of vascular dementia and alzheimer's disease in a defined elderly Japanese population: The hisayama study. Neurology 45, 1161-1168.
75. Kopf D, Frölich L (2009) Risk of incident alzheimer's disease in diabetic patients: A systematic review of prospective trials. J Alzheimers Dis 16, 677-685.
76. Bahrmann A, Bahrmann P, Kubiak T, Kopf D, Oster P, Sieber CC, Daniel WG (2012) Diabetes and dementia. Z Gerontol Geriatr 45, 17-22.
77. Wessels AM, Lane KA, Gao S, Hall KS, Unverzagt FW, Hendrie HC (2011) Diabetes and cognitive decline in elderly African Americans: A 15-year follow-up study. Alzheimers Dement 7, 418-424.
78. Beydoun MA, Beydoun HA, Wang Y (2008) Obesity and central obesity as risk factors for incident dementia and its subtypes; a systematic review and metaanalysis. Obes Rev 9, 204-218. (Pubitemid 351550691)
79. Luchsinger JA, Patel B, Tang MX, Schupf N, Mayeux R (2007) Measures of adiposity and dementia risk in elderly persons. Arch Neurol 64, 392-398. (Pubitemid 46425695)
80. Fitzpatrick AL, Kuller LH, Lopez OL, Diehr P, O'Meara ES, Longstreth WT Jr, Luchsinger JA (2009) Midlife and late-Life obesity and the risk of dementia: Cardiovascular health study. Arch Neurol 66, 336-342.
81. Yaffe K, Kanaya A, Lindquist K, Simonsick EM, Harris T, Shorr RI, Tylavsky FA, Newman AB (2004) The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA 292, 2237-2242. (Pubitemid 39473161)
82. Muller M, Tang MX, Schupf N, Manly JJ, Mayeux R, Luchsinger JA (2007) Metabolic syndrome and dementia risk in a multiethnic elderly cohort. Dement Geriatr Cogn Disord 24, 185-192. (Pubitemid 47312668)
83. Raffaitin C, Gin H, Empana JP, Helmer C, Berr C, Tzourio C, Portet F, Dartigues JF, Alp'erovitch A, Barberger-Gateau P (2009) Metabolic syndrome and risk for incident alzheimer's disease or vascular dementia The three-city study. Diabetes Care 32, 169-174.
84. Vanhanen M, Koivisto K, Moilanen L, Helkala EL, Hänninen T, Soininen H, Kervinen K, Kesäniemi YA, Laakso M, Kuusisto J (2006) Association of metabolic syndrome with alzheimer disease: A population-Based study. Neurology 67, 843-847. (Pubitemid 44394200)
85. Berry JD, Dyer A, Cai X, Garside DB, Ning H, Thomas A, Greenland P, Van Horn L, Tracy RP, Lloyd-Jones DM (2012) Lifetime risks of cardiovascular disease. N Engl J Med 366, 321-329.
86. Kivipelto M, Ngandu T, Laatikainen T, Winblad B, Soininen H, Tuomilheto J (2006) Risk score for the prevention of dementia risk in 20 years among middle aged people: A longitudinal, population-Based study. Lancet Neurol 5, 735741.
87. Luzzi S, Vella L, Bartolini M, Provinciali L, Silvestrini M (2010) Atherosclerosis in the evolution of alzheimer's disease: Can treatment reduce cognitive decline? J Alzheimers Dis 20, 893-890.
88. Waldstein SR, Rice Wendell C (2010) Neurocognitive function and cardiovascular disease. J Alzheimers Dis 20, 833842.
89. Jefferson AL (2010) Cardiac output as a potential risk factor for abnormal brain aging. J Alzheimers Dis 20, 813-821.
90. Correa de Toledo Ferraz Alves T, Kobuti Ferreira L, Wajngarten M, Busatto GF (2010) Cardiac disorders as risk factors for alzheimer's disease. J Alzheimers Dis 20, 749-763.
91. Gorelick PB, Scuteri A, Black SE, Decarli C, Greenberg SM, Iadecola C, Launer LJ, Laurent S, Lopez OL, Nyenhuis D, Petersen RC, Schneider JA, Tzourio C, Arnett DK, Bennett DA, Chui HC, Higashida RT, Lindquist R, Nilsson PM, Roman GC, Sellke FW, Seshadri S, American Heart Association Stroke Council, Council on Epidemiology and Prevention, Council on Cardiovascular Nursing, Council on Cardiovascular Radiology and Intervention, and Council on Cardiovascular Surgery and Anesthesia (2011) Vascular contributions to cognitive impairment and dementia: A statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 42, 26722713.
92. Mangialasche F, Kivipelto M, Solomon A, Fratiglioni L (2012) Dementia prevention: Current epidemiological evidence and future perspective. Alzheimers Res Ther 4, 6-14.
93. Polidori MC, Pientka L (2012) A brief update on dementia prevention. Z Gerontol Geriatr 45, 7-10.
94. Viswanathan A, Rocca WA, Tzourio C (2009) Vascular risk factors and dementia. How to move forward? Neurology 72, 368-374.
95. Barnes DE, Yaffe K (2009) Predicting dementia: Role of dementia risk indices. Future Neurol 4, 555-560.
96. de laTorre JC (2010)Vascular risk factor detection and control may prevent alzheimer's disease. Ageing Res Rev 9, 218-225.